Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

dose

dose is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 243
News articles 0
Drug details — dose
Class
—
Route
—
Patents
20
Programs
243
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

dose is an FDA-listed pharmaceutical active ingredient.

Key facts

INN dose

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 217848 Phase 3 · GSK Glaxo Smith · Respiratory Syncytial Virus Infections
  2. 608 dose Phase 3 · Sunshine Guojian Pharmaceutical · Ankylosing Spondylitis
  3. ALKS 9072, Low Dose Phase 3 · Alkermes Pharma Ireland · Schizophrenia
  4. CLI-05993AA5-06 Phase 3 · Chiesi Farmaceutici S.p.A · Uncontrolled Asthma
  5. Dose Phase 3 · United Therapeutics Europe · Chronic Migraine, Headache
  6. GWP42003-P 20 mg/kg/Day Dose Phase 3 · Jazz Pharmaceuticals Ireland · Epilepsy
  7. Guselkumab Dose 1 Phase 3 · Janssen Cilag International · Crohn's Disease
  8. High Dose Colchicine (4.8 mg total dose) Phase 3 · Takeda · Gout

Related patents

Browse patents

  1. WO 2026117667

    DOSES DE TITRATION DE MARIDEBART CAFRAGLUTIDE

    Expires Wed May 30 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12415794

    Pyridazinone compounds and uses thereof

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12404313

    GDNF fusion polypeptides and methods of use thereof

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12364737

    Activin receptor type IIA variants and methods of use thereof

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12350313

    Activin receptor type IIa variants and methods of use thereof

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12269858

    Activin receptor type IIB variants and methods of use thereof

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12240833

    Pyridazinone compounds and uses thereof

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12240831

    Pyridazinone compounds and uses thereof

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12084350

    Allotrope of carbon having increased electron delocalization

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12012395

    Pyridazinone compounds and uses thereof

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. AU 2022263543

    Pharmaceutical compositions comprising sorbitan esters

    Expires Wed May 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11933866

    Magnetic resonance maps for analyzing brain tissue

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11912750

    GDNF fusion polypeptides and methods of use thereof

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11892530

    Magnetic resonance maps for analyzing tissue

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11884715

    Activin receptor type IIB variants and methods of use thereof

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11820833

    Peptides that inhibit binding of EPCR to its ligand to treat inflammation

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11717558

    Nucleic acid molecules encoding activin receptor type IIA variants

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11718530

    Allotrope of carbon having increased electron delocalization

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11497793

    Compositions and methods for treating glioblastoma

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11484573

    Activin receptor type IIa variants and methods of use thereof

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is dose?

dose is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.